Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Piper Jaffray Expands Healthcare Investment Banking by Adding a Life Sciences Calling Officer

PIPR
Piper Jaffray Expands Healthcare Investment Banking by Adding a Life Sciences Calling Officer

Piper Jaffray (NYSE: PJC) is pleased to announce the addition of Peter Day as a managing director in the healthcare investment banking group. Day will be based in the firm’s Boston office focused on coverage of the biopharmaceutical sector.

Day brings more than 12 years of healthcare investment banking experience to Piper Jaffray. He joins the firm from Leerink Swann, where he was a senior calling officer in the healthcare group and was instrumental in building their biopharmaceutical business.

"We are excited to have Peter join our team,” commented Chad Abraham, global co-head of investment banking and capital markets at Piper Jaffray. “We continue to focus investment capital in our healthcare franchise to continue enhancing our highly ranked advisory and equities business. Also, adding a senior calling officer in Boston adds a strategically important coverage area to our biopharmaceutical efforts.”

Bob DeSutter, global head of healthcare investment banking added “Our healthcare group is a market-leading platform, serving emerging growth and established clients broadly across life sciences and healthcare services. Peter’s experience serving clients with advisory as well as the full suite of capital market products provides a great fit with our business.”

Piper Jaffray has a global healthcare investment banking and capital markets team of 46. Since 2007, the team has represented clients in 200 transactions with an aggregate value of $33 billion. In addition, the firm has 10 senior research analysts covering a broad spectrum of universes, including medical technology, drug discovery, medical diagnostics, life science tools, specialty pharmaceuticals and biotechnology, and healthcare services, including information technology, alternate site providers and contract research.

About Piper Jaffray
Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich. www.piperjaffray.com

Since 1895. Member FINRA, NYSE and SIPC.
© 2013 Piper Jaffray & Co.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today